Shopping Cart 0
Cart Subtotal
USD 0

BTG Plc (BTG) - Financial and Strategic SWOT Analysis Review

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: Yes
Copy Option: No
Deliverable Format : PDF Via Email

Single User License
USD 125

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: Yes
Copy Option: No
Deliverable Format : PDF Via Email

Site License
USD 250

Multiple Users within the Company/ Enterprise
Print Option: Yes
Copy Option: Yes
Deliverable Format : Excel, PDF Via Email

Corporate User License
USD 375
  • Details
  • Table Of Content
  • Licence Rights
  • Section Purchase
  • Products and Companies

Details

BTG Plc (BTG)-Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company's businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company's key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

The profile contains critical company information including:

- Business description-A detailed description of the company's operations and business divisions.

- Corporate strategy-Analyst's summarization of the company's business strategy.

- SWOT Analysis-A detailed analysis of the company's strengths, weakness, opportunities and threats.

- Company history-Progression of key events associated with the company.

- Major products and services-A list of major products, services and brands of the company.

- Key competitors-A list of key competitors to the company.

- Key employees-A list of the key executives of the company.

- Executive biographies-A brief summary of the executives' employment history.

- Key operational heads-A list of personnel heading key departments/functions.

- Important locations and subsidiaries-A list and contact details of key locations and subsidiaries of the company.

- Key manufacturing facilities-A list of key manufacturing facilities of the company.

- Detailed financial ratios for the past five years-The latest financial ratios derived from the annual financial statements published by the company with 5 years history.

- Interim ratios for the last five interim periods-The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Highlights

BTG plc (BTG) develops, manufactures and sells medicines for acute care, cancer and vascular diseases. The company develops specialty drugs including antidotes for snake envenomation and toxicity related to medicines used for heart conditions and cancer; interventional vascular products for treating patients with severe blood clots and varicose veins; and interventional cancer products for treating patients with liver tumors and emphysema. The company develops products and acquires or in-licenses from other companies. BTG markets its products either directly or through distribution agreements. The company operates along with its subsidiaries in the US, Europe and Asia. BTG is headquartered in London, England, the UK.

BTG Plc Key Recent Developments

Sep 11,2018: BTG buys vascular devices firm Novate Medical

Jun 21,2018: PERT Consortium and BTG Form Strategic Partnership

May 15,2018: BTG: Final Results For year ended 31 March 2018

Apr 04,2018: SIO and BTG Announce Recipients of Immuno-Oncology/Interventional Oncology Grant Program

Jan 23,2018: BTG Names As Anne Thorburn Non-executive Director of the Board

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.

- The profile analyzes the company's business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors' business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.

- The company's core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.

- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies' strategic, financial and operational performance.

- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.

- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company

READ MORE

Table Of Content

Scope

Table of Contents

Table of Contents 3

List of Tables 5

List of Figures 5

Section 1-About the Company 6

BTG Plc-Key Facts 6

BTG Plc-Key Employees 7

BTG Plc-Key Employee Biographies 8

BTG Plc-Major Products and Services 9

BTG Plc-History 10

BTG Plc-Company Statement 14

BTG Plc-Locations And Subsidiaries 15

Head Office 15

Other Locations & Subsidiaries 15

Section 2-Company Analysis 18

Company Overview 18

BTG Plc-Business Description 19

Business Segment: Interventional Medicine 19

Overview 19

Performance 19

Business Segment: Licensing 19

Overview 19

Performance 19

Business Segment: Pharmaceuticals 19

Overview 19

Performance 20

Geographical Segment: Europe 20

Performance 20

Geographical Segment: Other Regions 20

Performance 20

Geographical Segment: USA 20

Performance 20

R&D Overview 20

BTG Plc-Corporate Strategy 21

BTG Plc-SWOT Analysis 22

SWOT Analysis-Overview 22

BTG Plc-Strengths 22

BTG Plc-Weaknesses 23

BTG Plc-Opportunities 24

BTG Plc-Threats 25

BTG Plc-Key Competitors 26

Section 3-Company Financial Ratios 27

Financial Ratios-Capital Market Ratios 27

Financial Ratios-Annual Ratios 28

Performance Chart 31

Financial Performance 31

Financial Ratios-Interim Ratios 32

Financial Ratios-Ratio Charts 33

Section 4-Company's Lifesciences Financial Deals and Alliances 34

BTG Plc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 34

BTG Plc, Pharmaceuticals & Healthcare, Deals By Type, 2012 to YTD 2018 35

BTG Plc, Recent Deals Summary 36

Section 5-Company's Recent Developments 37

Sep 11, 2018: BTG buys vascular devices firm Novate Medical 37

Jun 21, 2018: PERT Consortium and BTG Form Strategic Partnership 38

May 15, 2018: BTG: Final Results For year ended 31 March 2018 39

Apr 04, 2018: SIO and BTG Announce Recipients of Immuno-Oncology/Interventional Oncology Grant Program 45

Nov 27, 2017: BTG Announced the Appointment of Non-executive Director 47

Nov 14, 2017: BTG: Directorate change-Chief Financial Officer 48

Nov 14, 2017: BTG: Interim Results 49

Sep 13, 2017: Vistogard and Voraxaze Added to Revised Guidelines for Stocking of Antidotes in US Hospitals 55

Aug 21, 2017: BTG and SIO Expand Immuno-Oncology / Interventional Oncology Grant Programme 56

Jun 16, 2017: ACCESS PTS Study Demonstrates Efficacy of EKOS Therapy for Post-Thrombotic Syndrome 57

Section 6-Appendix 58

Methodology 58

Ratio Definitions 58

About GlobalData 62

Contact Us 62

Disclaimer 62


List Of Figure

List of Figures

BTG Plc, Performance Chart (2014-2018) 31

BTG Plc, Ratio Charts 33

BTG Plc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 34

BTG Plc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 35


List Of Table

List of Tables

BTG Plc, Key Facts 6

BTG Plc, Key Employees 7

BTG Plc, Key Employee Biographies 8

BTG Plc, Major Products and Services 9

BTG Plc, History 10

BTG Plc, Subsidiaries 15

BTG Plc, Key Competitors 26

BTG Plc, Ratios based on current share price 27

BTG Plc, Annual Ratios 28

BTG Plc, Annual Ratios (Cont...1) 29

BTG Plc, Annual Ratios (Cont...2) 30

BTG Plc, Interim Ratios 32

BTG Plc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 34

BTG Plc, Pharmaceuticals & Healthcare, Deals By Type, 2012 to YTD 2018 35

BTG Plc, Recent Deals Summary 36

Currency Codes 58

Capital Market Ratios 58

Equity Ratios 59

Profitability Ratios 59

Cost Ratios 60

Liquidity Ratios 60

Leverage Ratios 61

Efficiency Ratios 61

Licence Rights

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License: 
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

Section Purchase

To know more information on Purchase by Section, please send a mail to support@kenresearch.com

Products and Companies

Products

BTG Plc, SWOT analysis, SWOT, Strengths, Weaknesses, Opportunities, Threats, Corporate Strategy, Key Ratios, Share Data, Performance, Financial Performance, Overview, Business Description, Major Product, Brands, History,Key Employees, Key Operational Heads, Strategy, Key Competitors, Company Statement, Capital Market Ratios, Financial Ratios, Annual Ratios, Interim Ratios, Ratio Charts


Companies

Transgene SA

Sirtex Medical Ltd

Merit Medical Systems Inc

Immupharma Plc

F. Hoffmann-La Roche Ltd

CeloNova BioSciences Inc

Baxter International Inc

BTG Plc (BTG)-Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company's businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company's key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

The profile contains critical company information including:

- Business description-A detailed description of the company's operations and business divisions.

- Corporate strategy-Analyst's summarization of the company's business strategy.

- SWOT Analysis-A detailed analysis of the company's strengths, weakness, opportunities and threats.

- Company history-Progression of key events associated with the company.

- Major products and services-A list of major products, services and brands of the company.

- Key competitors-A list of key competitors to the company.

- Key employees-A list of the key executives of the company.

- Executive biographies-A brief summary of the executives' employment history.

- Key operational heads-A list of personnel heading key departments/functions.

- Important locations and subsidiaries-A list and contact details of key locations and subsidiaries of the company.

- Key manufacturing facilities-A list of key manufacturing facilities of the company.

- Detailed financial ratios for the past five years-The latest financial ratios derived from the annual financial statements published by the company with 5 years history.

- Interim ratios for the last five interim periods-The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Highlights

BTG plc (BTG) develops, manufactures and sells medicines for acute care, cancer and vascular diseases. The company develops specialty drugs including antidotes for snake envenomation and toxicity related to medicines used for heart conditions and cancer; interventional vascular products for treating patients with severe blood clots and varicose veins; and interventional cancer products for treating patients with liver tumors and emphysema. The company develops products and acquires or in-licenses from other companies. BTG markets its products either directly or through distribution agreements. The company operates along with its subsidiaries in the US, Europe and Asia. BTG is headquartered in London, England, the UK.

BTG Plc Key Recent Developments

Sep 11,2018: BTG buys vascular devices firm Novate Medical

Jun 21,2018: PERT Consortium and BTG Form Strategic Partnership

May 15,2018: BTG: Final Results For year ended 31 March 2018

Apr 04,2018: SIO and BTG Announce Recipients of Immuno-Oncology/Interventional Oncology Grant Program

Jan 23,2018: BTG Names As Anne Thorburn Non-executive Director of the Board

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.

- The profile analyzes the company's business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors' business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.

- The company's core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.

- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies' strategic, financial and operational performance.

- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.

- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company

READ MORE

Scope

Table of Contents

Table of Contents 3

List of Tables 5

List of Figures 5

Section 1-About the Company 6

BTG Plc-Key Facts 6

BTG Plc-Key Employees 7

BTG Plc-Key Employee Biographies 8

BTG Plc-Major Products and Services 9

BTG Plc-History 10

BTG Plc-Company Statement 14

BTG Plc-Locations And Subsidiaries 15

Head Office 15

Other Locations & Subsidiaries 15

Section 2-Company Analysis 18

Company Overview 18

BTG Plc-Business Description 19

Business Segment: Interventional Medicine 19

Overview 19

Performance 19

Business Segment: Licensing 19

Overview 19

Performance 19

Business Segment: Pharmaceuticals 19

Overview 19

Performance 20

Geographical Segment: Europe 20

Performance 20

Geographical Segment: Other Regions 20

Performance 20

Geographical Segment: USA 20

Performance 20

R&D Overview 20

BTG Plc-Corporate Strategy 21

BTG Plc-SWOT Analysis 22

SWOT Analysis-Overview 22

BTG Plc-Strengths 22

BTG Plc-Weaknesses 23

BTG Plc-Opportunities 24

BTG Plc-Threats 25

BTG Plc-Key Competitors 26

Section 3-Company Financial Ratios 27

Financial Ratios-Capital Market Ratios 27

Financial Ratios-Annual Ratios 28

Performance Chart 31

Financial Performance 31

Financial Ratios-Interim Ratios 32

Financial Ratios-Ratio Charts 33

Section 4-Company's Lifesciences Financial Deals and Alliances 34

BTG Plc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 34

BTG Plc, Pharmaceuticals & Healthcare, Deals By Type, 2012 to YTD 2018 35

BTG Plc, Recent Deals Summary 36

Section 5-Company's Recent Developments 37

Sep 11, 2018: BTG buys vascular devices firm Novate Medical 37

Jun 21, 2018: PERT Consortium and BTG Form Strategic Partnership 38

May 15, 2018: BTG: Final Results For year ended 31 March 2018 39

Apr 04, 2018: SIO and BTG Announce Recipients of Immuno-Oncology/Interventional Oncology Grant Program 45

Nov 27, 2017: BTG Announced the Appointment of Non-executive Director 47

Nov 14, 2017: BTG: Directorate change-Chief Financial Officer 48

Nov 14, 2017: BTG: Interim Results 49

Sep 13, 2017: Vistogard and Voraxaze Added to Revised Guidelines for Stocking of Antidotes in US Hospitals 55

Aug 21, 2017: BTG and SIO Expand Immuno-Oncology / Interventional Oncology Grant Programme 56

Jun 16, 2017: ACCESS PTS Study Demonstrates Efficacy of EKOS Therapy for Post-Thrombotic Syndrome 57

Section 6-Appendix 58

Methodology 58

Ratio Definitions 58

About GlobalData 62

Contact Us 62

Disclaimer 62


List Of Figure

List of Figures

BTG Plc, Performance Chart (2014-2018) 31

BTG Plc, Ratio Charts 33

BTG Plc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 34

BTG Plc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 35


List Of Table

List of Tables

BTG Plc, Key Facts 6

BTG Plc, Key Employees 7

BTG Plc, Key Employee Biographies 8

BTG Plc, Major Products and Services 9

BTG Plc, History 10

BTG Plc, Subsidiaries 15

BTG Plc, Key Competitors 26

BTG Plc, Ratios based on current share price 27

BTG Plc, Annual Ratios 28

BTG Plc, Annual Ratios (Cont...1) 29

BTG Plc, Annual Ratios (Cont...2) 30

BTG Plc, Interim Ratios 32

BTG Plc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 34

BTG Plc, Pharmaceuticals & Healthcare, Deals By Type, 2012 to YTD 2018 35

BTG Plc, Recent Deals Summary 36

Currency Codes 58

Capital Market Ratios 58

Equity Ratios 59

Profitability Ratios 59

Cost Ratios 60

Liquidity Ratios 60

Leverage Ratios 61

Efficiency Ratios 61

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License: 
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

To know more information on Purchase by Section, please send a mail to support@kenresearch.com

Products

BTG Plc, SWOT analysis, SWOT, Strengths, Weaknesses, Opportunities, Threats, Corporate Strategy, Key Ratios, Share Data, Performance, Financial Performance, Overview, Business Description, Major Product, Brands, History,Key Employees, Key Operational Heads, Strategy, Key Competitors, Company Statement, Capital Market Ratios, Financial Ratios, Annual Ratios, Interim Ratios, Ratio Charts


Companies

Transgene SA

Sirtex Medical Ltd

Merit Medical Systems Inc

Immupharma Plc

F. Hoffmann-La Roche Ltd

CeloNova BioSciences Inc

Baxter International Inc